| 形态 | Liquid |
|---|
| 宿主种属 | Humanized |
|---|
| 克隆性 | Monoclonal |
|---|
| 抗体亚型 | half-IGG1-kappa/(scFv-kappa-heavy)-h-CH2-CH3 |
|---|
| 纯度 | >95% purity as determined by SDS-PAGE. |
|---|
| 纯化方式 | Protein A/G purified from cell culture supernatant. |
|---|
| 浓度 | 1mg/ml |
|---|
| 内毒素水平 | Please contact the lab for this information. |
|---|
| 应用 | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
|---|
| 种属反应性 | Human |
|---|
| 靶标 | Programmed cell death protein 1, Protein PD-1, hPD-1, PD1, PDCD1, CD279, CD152, Cytotoxic T-lymphocyte protein 4, CTLA-4, CTLA4, Cytotoxic T-lymphocyte-associated antigen 4 |
|---|
| 储存缓冲液 | 0.01M PBS, pH 7.4. |
|---|
| 稳定性和储存 | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
|---|
| 表达系统 | Mammalian Cells |
|---|
| 登录号 | Q15116 & P16410 |
|---|
| 背景信息 | Danvilostomig is an anti-CTLA4/PDCD1 monoclonal antibody.<br>• Cancer immunotherapy using checkpoint blockade., PMID:29567705<br/>• The blockade of immune checkpoints in cancer immunotherapy., PMID:22437870<br/>• Immune-related adverse events of checkpoint inhibitors., PMID:32382051<br/>• Immune Checkpoint Blockade in Cancer Therapy., PMID:25605845<br/>• Dermatologic Reactions to Immune Checkpoint Inhibitors : Skin Toxicities and Immunotherapy., PMID:29256113<br/>• Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination., PMID:27141885<br/>• Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints., PMID:30184160<br/>• Tumour- and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: a systematic review., PMID:28945858<br/>• Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer., PMID:34088360<br/>• Fundamental Mechanisms of Immune Checkpoint Blockade Therapy., PMID:30115704<br/> |
|---|
| 别名 | Bispecific, XmAb-20717, XMAB20717, 2329669-72-7 |
|---|
| 备注 | For research use only. Not suitable for clinical or therapeutic use. |
|---|